These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9288049)

  • 1. Is there tissue penetration after application of topical salicylate formulations?
    Cross SE; Anderson C; Thompson MJ; Roberts MS
    Lancet; 1997 Aug; 350(9078):636. PubMed ID: 9288049
    [No Abstract]   [Full Text] [Related]  

  • 2. Percutaneous absorption of salicylates from some commercially available topical products containing methyl salicylate or salicylate salts in rats.
    Megwa SA; Benson HA; Roberts MS
    J Pharm Pharmacol; 1995 Nov; 47(11):891-6. PubMed ID: 8708981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies.
    Cross SE; Anderson C; Roberts MS
    Br J Clin Pharmacol; 1998 Jul; 46(1):29-35. PubMed ID: 9690946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H
    Liang X; Chen YL; Jiang XJ; Wang SM; Zhang JW; Gui SY
    Eur J Pharm Sci; 2017 Mar; 100():155-162. PubMed ID: 28063969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phonophoresis on serum salicylate levels.
    Oziomek RS; Perrin DH; Herold DA; Denegar CR
    Med Sci Sports Exerc; 1991 Apr; 23(4):397-401. PubMed ID: 2056895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiated in vivo skin penetration of salicylic compounds in hairless rats measured by cutaneous microdialysis.
    Simonsen L; Jørgensen A; Benfeldt E; Groth L
    Eur J Pharm Sci; 2004 Feb; 21(2-3):379-88. PubMed ID: 14757512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of l-menthol and dl-camphor on the penetration and hydrolysis of methyl salicylate in hairless mouse skin.
    Yano T; Kanetake T; Saita M; Noda K
    J Pharmacobiodyn; 1991 Dec; 14(12):663-9. PubMed ID: 1812275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern Intermittent Haemodialysis (IHD) is an Effective Method of Removing Salicylate in Chronic Topical Salicylate Toxicity.
    Wong A; Mac K; Aneman A; Wong J; Chan BS
    J Med Toxicol; 2016 Mar; 12(1):130-3. PubMed ID: 26334327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self promotion of deep tissue penetration and distribution of methylsalicylate after topical application.
    Cross SE; Megwa SA; Benson HA; Roberts MS
    Pharm Res; 1999 Mar; 16(3):427-33. PubMed ID: 10213375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percutaneous penetration of drugs--application in physical therapy].
    Clarys P; Barel A; Taeymans J
    Sportverletz Sportschaden; 1997 Dec; 11(4):XIX-XXIII. PubMed ID: 9491473
    [No Abstract]   [Full Text] [Related]  

  • 11. Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application.
    Singh P; Roberts MS
    J Pharmacokinet Biopharm; 1993 Aug; 21(4):337-73. PubMed ID: 8133461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous absorption, disposition, and exposure assessment of homosalate, a UV filtering agent, in rats.
    Kim TH; Shin BS; Kim KB; Shin SW; Seok SH; Kim MK; Kim EJ; Kim D; Kim MG; Park ES; Kim JY; Yoo SD
    J Toxicol Environ Health A; 2014; 77(4):202-13. PubMed ID: 24555679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of penetration enhancer on drug permeation from volatile formulations.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Int J Pharm; 2012 Dec; 439(1-2):260-8. PubMed ID: 23000063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal drug transport and metabolism. I. Comparison of in vitro and in vivo results.
    Guzek DB; Kennedy AH; McNeill SC; Wakshull E; Potts RO
    Pharm Res; 1989 Jan; 6(1):33-9. PubMed ID: 2717514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdialysis sampling and the clinical determination of topical dermal bioequivalence.
    McCleverty D; Lyons R; Henry B
    Int J Pharm; 2006 Feb; 308(1-2):1-7. PubMed ID: 16364577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermal copper drugs: the copper bracelet and cu(II) salicylate complexes.
    Walker WR; Beveridge SJ; Whitehouse MW
    Agents Actions Suppl; 1981; 8():359-67. PubMed ID: 7008557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional differences in the in vitro penetration of methylsalicylate through equine skin.
    Mills PC; Cross SE
    Vet J; 2007 Jan; 173(1):57-61. PubMed ID: 16246600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal drug transport and metabolism. II. The role of competing kinetic events.
    Potts RO; McNeill SC; Desbonnet CR; Wakshull E
    Pharm Res; 1989 Feb; 6(2):119-24. PubMed ID: 2762211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of triethanolamine salicylate release from the dermatological bases and the commercial products.
    Babar A; Chickhale PJ; Plakogiannis FM
    Pharm Acta Helv; 1991; 66(12):322-8. PubMed ID: 1784579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous absorption of salicylic acid after repeated (14-day) in vivo administration to normal, acnegenic or aged human skin.
    Davis DA; Kraus AL; Thompson GA; Olerich M; Odio MR
    J Pharm Sci; 1997 Aug; 86(8):896-9. PubMed ID: 9269866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.